soul trial oral semaglutide cardiovascular outcomes 2024 nejm results Forecasting Trial Milestones: A Predictive Analysis for Early Termination of the SOUL Study soul trial oral semaglutide cardiovascular

Our core values guide everything we do, including the standards we use to ensure the quality and trustworthiness of our content and editorial processes

While not always required, patients with diabetes often benefit from endocrinologist care, especially if they have poorly controlled blood sugar, complications, or take multiple diabetes medications

Current medications like Ozempic or Zepbound only hit one or two of those pathways, which is likely why early data is showing more dramatic results. New research on retatrutide benefits for weight loss According to NBC News , the newest phase 3 clinical trial found that people taking retatrutide lost up to 85 pounds, essentially 30 percent of their body weight, which is not too dissimilar to the percentage of body weight people lose after bariatric surgery, which is 25 to 35 percent within one to two years, per NBC News referencing data from Circulation Research

The table below outlines key risk stratifiers that should inform your provider's safety assessment before starting or adjusting semaglutide therapy

Use the reconstitution volume guidelines from the tables above